The role of dipeptidyl peptidase 4 inhibitors in fat metabolism in patients with type 2 diabetes and obesity

The role of dipeptidyl peptidase 4 inhibitors in fat metabolism in patients with type 2 diabetes and obesity

Objective. To evaluate the influence of combined therapy of sitagliptin and metformin on fat metabolism in patients with type 2 diabetes mellitus. Methods. The study included 82 patients (age, 55.3±9.1 years) with obesity and lipid metabolism disorders. None of the patients had reached their targe...

Full description

Bibliographic Details
Main Authors:	Aleksander Sergeevich Ametov, Dinara Gadgimagomedovna Gusenbekova
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2015-07-01
Series:	Сахарный диабет
Subjects:	sitagliptin visceral fat fat metabolism type 2 diabetes
Online Access:	https://dia-endojournals.ru/dia/article/viewFile/6969/5490

Similar Items

Effect of dipeptidyl peptidase-4 inhibitors on fat metabolism in patients with type 2 diabetes mellitus
by: A S Ametov, et al.
Published: (2014-08-01)

Nonglycemic effects of dipeptidyl peptidase-4 inhibitors
by: A S Ametov, et al.
Published: (2013-01-01)

Visceral-to-subcutaneous fat ratio as a predictor of the multiple metabolic risk factors for subjects with normal waist circumference in Korea
by: Oh YH, et al.
Published: (2017-12-01)

Ultrasound Evaluation of Visceral Fat Thickness for Prediction of Metabolic Syndrome in the First Trimester of Pregnancy in a Sample of Non-obese Iranian Women
by: Firoozeh Ahmadi, et al.
Published: (2019-07-01)

Subcutaneous to visceral fat ratio: a possible risk factor for metabolic syndrome and cardiovascular diseases
by: Shafqat MN, et al.
Published: (2018-04-01)

Natural dipeptidyl peptidase-IV inhibitor mangiferin mitigates diabetes- and metabolic syndrome-induced changes in experimental rats
by: Suman RK, et al.
Published: (2016-08-01)

Relationship between Abdominal Fat Area Measured by Screening Abdominal Fat CT and Metabolic Syndrome in Asymptomatic Korean Individuals
by: Dae Woong Park, et al.
Published: (2017-07-01)

Metabolic syndrome and visceral fat thickness in obese adolescents
by: Lanny C. Gultom, et al.
Published: (2007-07-01)

Subcutaneous fat mass is associated with genetic risk scores related to proinflammatory cytokine signaling and interact with physical activity in middle-aged obese adults
by: James W. Daily, et al.
Published: (2019-11-01)

Gallstone disease and obesity: a population-based study on abdominal fat distribution and gender differences
by: Amir Reza Radmard, et al.
Published: (2015-09-01)

Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus
by: Yayoi Nishida, et al.
Published: (2020-04-01)

Correlation of epicardial fat and anthropometric measurements in Asian-Indians: A community based study
by: Ranjan Shetty, et al.
Published: (2012-10-01)

Phenotypes of Sarcopenic Obesity: Exploring the Effects on Peri-Muscular Fat, the Obesity Paradox, Hormone-Related Responses and the Clinical Implications
by: Tariq A. Alalwan
Published: (2020-02-01)

Vascular wall status and its link with perivascular adipose tissue and other fat depots in young patients with abdominal obesity
by: Ekaterina A Zheleznova, et al.
Published: (2019-12-01)

Hepatoprotective effect of dipeptidyl peptidase-4 inhibitor sitagliptin against carbon tetrachloride-induced liver fibrosis in mice
by: Ahmed A.N Ahmed, et al.
Published: (2021-01-01)

BODY COMPOSITION AND ITS ROLE IN DEVELOPMENT OF METABOLIC DISORDERS AND CARDIOVASCULAR DISEASES
by: O. M. Drapkina, et al.
Published: (2017-10-01)

Vitamin C is Not Related to Resting Fat Oxidation in Healthy, Non-Obese Adults
Published: (2014)

The Relationship between Abdominal Fat Phenotypes and Insulin Resistance in Non-Obese Individuals after Acute Pancreatitis
by: Juyeon Ko, et al.
Published: (2020-09-01)

Four Weeks Exercise in Vary Intensities Reduce More Inguinal Fat Than Perigonadal Fat in Mice
by: Ahmad Rukhani Lutfi, et al.
Published: (2021-06-01)

DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS
by: Erna Kristin
Published: (2016-12-01)

Algorithm for radiological examination of visceral obesity in patients with metabolic syndrome
by: N. M. Suslyayeva, et al.
Published: (2012-10-01)

Waist circumference measurement sites and their association with visceral and subcutaneous fat and cardiometabolic abnormalities
by: Cláudia Porto Sabino Pinho, et al.

Total adiponectin in overweight and obese subjects and its response to visceral fat loss
by: Salah Gariballa, et al.
Published: (2019-06-01)

The Impact of Serum Zinc Levels on Abdominal Fat Mass in Hemodialysis Patients
by: Hirotaka Fukasawa, et al.
Published: (2020-02-01)

Compartmental fat distribution in the abdomen of dogs relative to overall body fat composition
by: R. B. S. Turner, et al.
Published: (2020-03-01)

Internal Fat and Cardiometabolic Risk Factors Following a Meal-Replacement Regimen vs. Comprehensive Lifestyle Changes in Obese Subjects
by: Daniel König, et al.
Published: (2015-12-01)

Visceral fat correlation with sympathetic neuronal activity in women
by: Rama Kranthi, et al.
Published: (2014-06-01)

Occurrence of diabetes mellitus in obese nondiabetic patients, with correlative analysis of visceral fat, fasting insulin, and insulin resistance: A 3-year follow-up study (mysore visceral adiposity in diabetes follow-up study)
by: M Premanath, et al.
Published: (2017-01-01)

The Correlation between the Ratio of Visceral Fat Area to Subcutaneous Fat Area on Computed Tomography and Lipid Accumulation Product as Indexes of Cardiovascular Risk
by: SoHee Kwon, et al.
Published: (2019-09-01)

Skeletal muscle mass to visceral fat area ratio is an important determinant associated with type 2 diabetes and metabolic syndrome
by: Wang Q, et al.
Published: (2019-08-01)

Combination treatment for type 2 diabetes mellitus (T2DM) : dipeptidyl peptidase-4 inhibitors (DPP-4) and metformin
by: Erna Kristin
Published: (2017-10-01)

The Relationship Between Abdominal Body Composition and Metabolic Syndrome After a Weight Reduction Program in Adult Men with Obesity
by: Liao CC, et al.
Published: (2020-01-01)

Obesity prevalence rate, depending on various criteria in the average age population of urban and rural residents of the Siberian region
by: D. P. Tsygankova, et al.
Published: (2019-09-01)

Frozen Autoclaved Sorghum Enhanced Colonic Fermentation and Lower Visceral Fat Accumulation in Rats
by: Samanthi W. Pelpolage, et al.
Published: (2020-08-01)

Optimal Cut-Off Values of Visceral Fat Area for Predicting Metabolic Syndrome Among Type 2 Diabetes Patients in Ningbo, China
by: Yang X, et al.
Published: (2021-03-01)

High prevalence of gastroesophageal reflux symptoms in type 2 diabetics with hypoadiponectinemia and metabolic syndrome
by: Hirata Ayumu, et al.
Published: (2012-01-01)

Epicardial Fat Thickness and Bone Mineral Content: The Healthy Twin Study in Korea
by: Dong-won Lee, et al.
Published: (2018-05-01)

Deciphering CT texture features of human visceral fat to evaluate metabolic disorders and surgery-induced weight loss effects
by: Juan Shi, et al.
Published: (2021-07-01)

Effect of High Fat Diet on Body Weight, Visceral Fat Weight, and PPARG Expressions on Visceral Fat in Mice
by: Cantika Putri Melyana, et al.
Published: (2021-09-01)

Postprandial plasma acylation stimulating protein response and fat metabolism in post-obese women
by: Faraj, May.
Published: (1999)